Carol M Richman, MD

Professor Emeritus

  • 2131 Citations
  • 25 h-Index
1976 …2017

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Carol M Richman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

STUDIES TO IMPROVE CANCER THERAPY WITH ANTIBODIES

Meares, C. F., Richman, C. M., Lam, K., De Nardo, S., O'Donnell, R., Colvin, M., Denardo, S., Hartmann-Siantar, C., Lamborn, K., Larkin, E., Salako, Q., Gumerlock, P., Shen, S. U. I., Denardo, S., Denardo, G. & Denardo, G. L.

National Institutes of Health

7/15/883/31/09

Project: Research project

  • Research Output

    • 2131 Citations
    • 25 h-Index
    • 61 Article
    • 1 Chapter

    Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: A CIBMTR analysis

    Kanate, A. S., Digilio, A., Ahn, K. W., Al Malki, M., Jacobsen, E., Steinberg, A., Hamerschlak, N., Kharfan-Dabaja, M., Salit, R., Ball, E., Bashir, Q., Cashen, A., Couriel, D., Diez-Martin, J., Katsanis, E., Linhares, Y., Mori, S., Nash, R., Pawarode, A., Perales, M. A. & 11 others, Phipps, C. D., Richman, C. M., Savani, B. N., Shapira, M. Y., Stiff, P., Strair, R., Fenske, T. S., Smith, S. M., Sureda, A., Olteanu, H. & Hamadani, M., 2017, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journalArticle

    22 Scopus citations

    Outcomes of Allogeneic Hematopoietic cell transplantation in patients with Dyskeratosis Congenita

    Gadalla, S. M., Sales-Bonfim, C., Carreras, J., Alter, B. P., Antin, J. H., Ayas, M., Bodhi, P., Davis, J., Davies, S. M., Deconinck, E., Deeg, H. J., Duerst, R. E., Fasth, A., Ghavamzadeh, A., Giri, N., Goldman, F. D., Kolb, E. A., Krance, R., Kurtzberg, J., Leung, W. H. & 11 others, Srivastava, A., Or, R., Richman, C. M., Rosenberg, P. S., Toledo Codina, J. S. D., Shenoy, S., Socié, G., Tolar, J., Williams, K. M., Eapen, M. & Savage, S. A., Aug 2013, In : Biology of Blood and Marrow Transplantation. 19, 8, p. 1238-1243 6 p.

    Research output: Contribution to journalArticle

  • 64 Scopus citations

    Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer

    Lehmann, J., DeNardo, G. L., Yuan, A., Shen, S., O'Donnell, R. T., Richman, C. M. & DeNardo, S. J., Nov 15 2006, In : International Journal of Radiation Oncology Biology Physics. 66, 4, p. 1192-1198 7 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Does paclitaxel (taxol) given after111In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?

    Miers, L., Lamborn, K., Yuan, A., Richman, C. M., Natarajan, A., DeNardo, S. & Denardo, G. L., Oct 1 2005, In : Clinical Cancer Research. 11, 19 II

    Research output: Contribution to journalArticle

  • 8 Scopus citations

    Enhancement of the therapeutic index: From nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer

    DeNardo, S. J., Richman, C. M., Albrecht, H., Burke, P. A., Natarajan, A., Yuan, A., Gregg, J., O'Donnell, R. T. & Denardo, G. L., Oct 1 2005, In : Clinical Cancer Research. 11, 19 II

    Research output: Contribution to journalArticle

  • 25 Scopus citations